UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission

Journal of clinical oncology, 2012-09, Vol.30 (26), p.3264-3270

2012

Volltextzugriff (PDF)

Key role for myeloid cells: Phase II results of anti‐GD2 antibody 3F8 plus granulocyte‐macrophage colony‐stimulating factor for chemoresistant osteomedullary neuroblastoma

International journal of cancer, 2014-11, Vol.135 (9), p.2199-2205

2014

Volltextzugriff (PDF)

A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors

PloS one, 2017-06, Vol.12 (6), p.e0178593-e0178593

2017

Volltextzugriff (PDF)

Local Control With 21-Gy Radiation Therapy for High-Risk Neuroblastoma

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.393-400

2016

Volltextzugriff (PDF)

Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study

Oncoimmunology, 2018-01, Vol.7 (8), p.e1461305-e1461305

2018

Volltextzugriff (PDF)

Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma

Cancers, 2021-12, Vol.13 (24), p.6265

2021

Volltextzugriff (PDF)

Re‐thinking transplant for neuroblastoma

Pediatric blood & cancer, 2021-06, Vol.68 (6), p.e28961-n/a

Kushner, Brian H.

2021

Volltextzugriff (PDF)

Outpatient administration of naxitamab in combination with granulocyte‐macrophage colony‐stimulating factor in patients with refractory and/or relapsed high‐risk neuroblastoma: Management of adverse events

Cancer reports, 2023-01, Vol.6 (1), p.e1627-n/a

2023

Volltextzugriff (PDF)

Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease

Frontiers in oncology, 2023-01, Vol.12, p.1106597-1106597

2023

Volltextzugriff (PDF)

Irinotecan Plus Temozolomide for Relapsed or Refractory Neuroblastoma

Journal of clinical oncology, 2006-11, Vol.24 (33), p.5271-5276

2006

Volltextzugriff (PDF)

Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival

Oncoimmunology, 2017-11, Vol.6 (11), p.e1358331

2017

Volltextzugriff (PDF)

Long Prime–Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer Vaccine

Vaccines (Basel), 2024-06, Vol.12 (6), p.587

2024

Volltextzugriff (PDF)

Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk Neuroblastoma

Journal of clinical oncology, 2009-03, Vol.27 (7), p.1041-1046

2009

Volltextzugriff (PDF)

Ifosfamide, carboplatin, and etoposide for neuroblastoma

Cancer, 2013-02, Vol.119 (3), p.665-671

2013

Volltextzugriff (PDF)

Reduced Toxicity With Intensity Modulated Radiation Therapy (IMRT) for Desmoplastic Small Round Cell Tumor (DSRCT): An Update on the Whole Abdominopelvic Radiation Therapy (WAP-RT) Experience

International journal of radiation oncology, biology, physics, 2013, Vol.85 (1), p.e67-e72

2013

Volltextzugriff (PDF)

Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies

Journal of hematology and oncology, 2022-11, Vol.15 (1), p.1-12, Article 165

2022

Volltextzugriff (PDF)

Long-term Pulmonary Outcomes in Pediatric Survivors of High-risk Neuroblastoma

Journal of pediatric hematology/oncology, 2017-10, Vol.39 (7), p.547-554

2017

Volltextzugriff (PDF)

Chemoimmunotherapy for high-risk neuroblastoma

The lancet oncology, 2017-07, Vol.18 (7), p.845-846

Kushner, Brian H

2017

Volltextzugriff (PDF)

FCGR2A Polymorphism Is Correlated With Clinical Outcome After Immunotherapy of Neuroblastoma With Anti-GD2 Antibody and Granulocyte Macrophage Colony-Stimulating Factor

Journal of clinical oncology, 2006-06, Vol.24 (18), p.2885-2890

2006

Volltextzugriff (PDF)

Reduction From Seven to Five Cycles of Intensive Induction Chemotherapy in Children With High-Risk Neuroblastoma

Journal of clinical oncology, 2004-12, Vol.22 (24), p.4888-4892

2004

Volltextzugriff (PDF)

Short Hypofractionated Radiation Therapy in Palliation of Pediatric Malignancies: Outcomes and Toxicities

International journal of radiation oncology, biology, physics, 2018-12, Vol.102 (5), p.1457-1464

2018

Volltextzugriff (PDF)

Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study

The Journal of nuclear medicine (1978), 2016-02, Vol.57 (2), p.231-237

2016

Volltextzugriff (PDF)

Long-term complications in survivors of advanced stage neuroblastoma

Pediatric Blood & Cancer, 2005-09, Vol.45 (3), p.324-332

2005

Volltextzugriff (PDF)

Long-Term Event-Free Survival After Intensive Chemotherapy for Ewing’s Family of Tumors in Children and Young Adults

Journal of clinical oncology, 2003-09, Vol.21 (18), p.3423-3430

2003

Volltextzugriff (PDF)

Neuroblastoma: A Disease Requiring a Multitude of Imaging Studies

The Journal of nuclear medicine (1978), 2004-07, Vol.45 (7), p.1172-1188

Kushner, Brian H

2004

Volltextzugriff (PDF)

1 – 25 von 232

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(210)
Mit Volltextzugriff
(206)

Publikationsform

Sprache

Englisch
(231)
Japanisch
(32)

Erscheinungsjahr

n.n

Thema

Humans
(152)
Science & Technology
(143)
Life Sciences & Biomedicine
(140)
Oncology
(114)
Male
(98)
Female
(97)
Child
(89)
Child, Preschool
(81)
Biological And Medical Sciences
(72)
Neuroblastoma
(71)
Medical Sciences
(69)
Adolescent
(67)
Infant
(64)
Pediatrics
(51)
Neuroblastoma - Drug Therapy
(48)
Adult
(46)
Neuroblastoma - Pathology
(44)
Neuroblastoma - Therapy
(40)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(37)
Immunotherapy
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission

Key role for myeloid cells: Phase II results of anti‐GD2 antibody 3F8 plus granulocyte‐macrophage colony‐stimulating factor for chemoresistant osteomedullary neuroblastoma

A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors

Local Control With 21-Gy Radiation Therapy for High-Risk Neuroblastoma

Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study

Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma

Re‐thinking transplant for neuroblastoma

Outpatient administration of naxitamab in combination with granulocyte‐macrophage colony‐stimulating factor in patients with refractory and/or relapsed high‐risk neuroblastoma: Management of adverse events

Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease

Irinotecan Plus Temozolomide for Relapsed or Refractory Neuroblastoma

Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival

Long Prime–Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer Vaccine

Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk Neuroblastoma

Ifosfamide, carboplatin, and etoposide for neuroblastoma

Reduced Toxicity With Intensity Modulated Radiation Therapy (IMRT) for Desmoplastic Small Round Cell Tumor (DSRCT): An Update on the Whole Abdominopelvic Radiation Therapy (WAP-RT) Experience

Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies

Long-term Pulmonary Outcomes in Pediatric Survivors of High-risk Neuroblastoma

Chemoimmunotherapy for high-risk neuroblastoma

FCGR2A Polymorphism Is Correlated With Clinical Outcome After Immunotherapy of Neuroblastoma With Anti-GD2 Antibody and Granulocyte Macrophage Colony-Stimulating Factor

Reduction From Seven to Five Cycles of Intensive Induction Chemotherapy in Children With High-Risk Neuroblastoma

Short Hypofractionated Radiation Therapy in Palliation of Pediatric Malignancies: Outcomes and Toxicities

Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study

Long-term complications in survivors of advanced stage neuroblastoma

Long-Term Event-Free Survival After Intensive Chemotherapy for Ewing’s Family of Tumors in Children and Young Adults

Neuroblastoma: A Disease Requiring a Multitude of Imaging Studies

Suchergebnisse filtern